These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29774518)

  • 1. HuH-7 reference genome profile: complex karyotype composed of massive loss of heterozygosity.
    Kasai F; Hirayama N; Ozawa M; Satoh M; Kohara A
    Hum Cell; 2018 Jul; 31(3):261-267. PubMed ID: 29774518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic analysis of BC2, a new human hepatoma cell line, by fluorescent in situ hybridization.
    Ingster O; Hamon-Benais C; Couturier-Turpin MH; Guguen-Guillouzo C; Lucas J; Bernheim A; Feldmann G
    Ann Genet; 1996; 39(3):123-8. PubMed ID: 8839883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
    Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
    BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The PLC/PRF/5 human hepatoma cell line. I. Reevaluation of the karyotype.
    Pinto MR; Bey E; Bernstein R
    Cancer Genet Cytogenet; 1985 Sep; 18(1):11-8. PubMed ID: 2992761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interphase cytogenetic studies of human hepatocellular carcinomas by fluorescent in situ hybridization.
    Hamon-Benais C; Ingster O; Terris B; Couturier-Turpin MH; Bernheim A; Feldmann G
    Hepatology; 1996 Mar; 23(3):429-35. PubMed ID: 8617421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytogenetic and molecular genetic alterations on chromosome 4q in human hepatocellular carcinoma].
    Zhang HK; Wang HY; Xia JC
    Ai Zheng; 2008 Sep; 27(9):998-1005. PubMed ID: 18799044
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of permanent cell lines from primary, metastatic and recurrent malignant peripheral nerve sheath tumors (MPNST) with underlying neurofibromatosis-1.
    Fang Y; Elahi A; Denley RC; Rao PH; Brennan MF; Jhanwar SC
    Anticancer Res; 2009 Apr; 29(4):1255-62. PubMed ID: 19414372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genome signatures of colon carcinoma cell lines.
    Kleivi K; Teixeira MR; Eknaes M; Diep CB; Jakobsen KS; Hamelin R; Lothe RA
    Cancer Genet Cytogenet; 2004 Dec; 155(2):119-31. PubMed ID: 15571797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Detection of Hep-2 and hepatoma cell line chromosomal aberration by using fluorescence in situ hybridization].
    Pan S; Zhang X; Wang F; Zhao W; Li C; Chen Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 1998 Oct; 15(5):278-80. PubMed ID: 9758872
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A combination of molecular cytogenetic analyses reveals complex genetic alterations in conventional renal cell carcinoma.
    Strefford JC; Stasevich I; Lane TM; Lu YJ; Oliver T; Young BD
    Cancer Genet Cytogenet; 2005 May; 159(1):1-9. PubMed ID: 15860350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The abnormalities of chromosome 8 in two hepatocellular carcinoma cell clones with the same genetic background and different metastatic potential.
    Yang J; Qin LX; Ye SL; Liu YK; Li Y; Gao DM; Chen J; Tang ZY
    J Cancer Res Clin Oncol; 2003 May; 129(5):303-8. PubMed ID: 12750998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Infrequent amplification of JUN in hepatocellular carcinoma.
    Endo M; Yasui K; Nakajima T; Gen Y; Tsuji K; Dohi O; Zen K; Mitsuyoshi H; Minami M; Itoh Y; Taniwaki M; Tanaka S; Arii S; Okanoue T; Yoshikawa T
    Anticancer Res; 2009 Dec; 29(12):4989-94. PubMed ID: 20044606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular and cholangiolar carcinoma-derived cell lines reveal distinct sets of chromosomal imbalances.
    Wilkens L; Hammer C; Glombitza S; Müller DE
    Pathobiology; 2012; 79(3):115-26. PubMed ID: 22261732
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytogenetic and molecular genetic alterations in hepatocellular carcinoma.
    Lau SH; Guan XY
    Acta Pharmacol Sin; 2005 Jun; 26(6):659-65. PubMed ID: 15916730
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LS-CAP: an algorithm for identifying cytogenetic aberrations in hepatocellular carcinoma using microarray data.
    He X; Wei Q; Sun M; Fu X; Fan S; Li Y
    Front Biosci; 2006 May; 11():1311-22. PubMed ID: 16368518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of chromosome 1 and loss of heterozygosity on 1p in primary hepatomas.
    Simon D; Knowles BB; Weith A
    Oncogene; 1991 May; 6(5):765-70. PubMed ID: 1646986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of rearrangements involving 4q, 13q and 16q in hepatocellular carcinoma cell lines using region-specific multiplex-FISH probes.
    Tjia WM; Hu L; Zhang MY; Guan XY
    Cancer Lett; 2007 May; 250(1):92-9. PubMed ID: 17098359
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in molecular diagnostics of colorectal cancer by genomic arrays: proposal for a procedural shift in biological sampling and pathological report.
    Castorina S; Barresi V; Luca T; Privitera G; Musso N; Capizzi C; Condorelli DF
    Ital J Anat Embryol; 2010; 115(1-2):39-45. PubMed ID: 21072988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse p53 gene aberration in hepatocellular carcinoma detected by dual-color fluorescence in situ hybridization.
    Kondo M; Marusawa H; Ueda Y; Katsurada A; Kawasome C; Takami S; Kinoshita M; Ikai I; Yamaoka Y; Chiba T
    J Gastroenterol Hepatol; 2004 Sep; 19(9):1066-73. PubMed ID: 15304126
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.